Cargando…

Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals

BACKGROUND: The first line anti-tuberculosis drugs isoniazid (INH), rifampicin (RIF) and pyrazinamide (PZA) continues to be the effective drugs in the treatment of tuberculosis, however, the use of these drugs is associated with toxic reactions in tissues, particularly in the liver, leading to hepat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eminzade, Sude, Uras, Fikriye, Izzettin, Fikret V
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2491620/ https://www.ncbi.nlm.nih.gov/pubmed/18601745 http://dx.doi.org/10.1186/1743-7075-5-18

Ejemplares similares

Protective effect of silymarin on tacrolimus-induced kidney and liver toxicity
por: Terzi, Funda, et al.
Publicado: (2022)

Protective Effect of Silymarin on Liver in Experimental in the Sepsis Model of Rats
por: Aydemir Celep, Nevra, et al.
Publicado: (2023)

Protective effects of silymarin against bisphenol A-induced hepatotoxicity in mouse liver
por: Zaulet, Mihaela, et al.
Publicado: (2017)

Protective effect of silymarin against chemical-induced cardiotoxicity
por: Razavi, Bibi Marjan, et al.
Publicado: (2016)

Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial
por: Marjani, Majid, et al.
Publicado: (2019)

Hepatoprotective effects of silymarin in management of liver injury caused by tuberculosis treatment
por: Lee, Yeong Yeh, et al.
Publicado: (2023)

Effect of Prophylactic Use of Silymarin on Anti-tuberculosis Drugs Induced Hepatotoxicity
por: Heo, Eunyoung, et al.
Publicado: (2017)

Protective Effect of Silymarin against Acrolein-Induced Cardiotoxicity in Mice
por: Taghiabadi, Elahe, et al.
Publicado: (2012)

The protective effects of silymarin nanoemulsion on 5-fluorouracil-induced gastrointestinal toxicity in rats
por: Safarpour, Soheila, et al.
Publicado: (2023)

Hepatoprotective and renoprotective effects of silymarin against salinomycin-induced toxicity in adult rabbits
por: Ghonaim, Ahmed H., et al.
Publicado: (2022)

Silymarin’s Protective Effects and Possible Mechanisms on Alcoholic Fatty Liver for Rats
por: Zhang, Wei, et al.
Publicado: (2013)

Protective effect of rutin in comparison to silymarin against induced hepatotoxicity in rats
por: Reddy, M. Kasi, et al.
Publicado: (2017)

The Protective Effects of Silymarin against Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity in Rats
por: Rašković, Aleksandar, et al.
Publicado: (2011)

Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis
por: El-Lakkany, Naglaa M, et al.
Publicado: (2012)

Protective Effects of Silymarin and Silibinin against DNA Damage in Human Blood Cells
por: Fernandes Veloso Borges, Flávio, et al.
Publicado: (2018)

Protective Effect of Silymarin and Gallic Acid against Cisplatin-Induced Nephrotoxicity and Hepatotoxicity
por: Doğan, Duygu, et al.
Publicado: (2022)

Skin Protective Activity of Silymarin and its Flavonolignans
por: Vostálová, Jitka, et al.
Publicado: (2019)

Investigating the impact of silymarin on liver oxidative injury
por: Jamalian, Mohammad, et al.
Publicado: (2020)

Beyond the liver protective efficacy of silymarin; bright renoprotective effect on diabetic kidney disease
por: Amiri, Masoud, et al.
Publicado: (2014)

Preclinical Long-term Magnetic Resonance Imaging Study of Silymarin Liver-protective Effects
por: Chae, Yeon Ji, et al.
Publicado: (2022)

Silymarin Encapsulated Liposomal Formulation: An Effective Treatment Modality against Copper Toxicity Associated Liver Dysfunction and Neurobehavioral Abnormalities in Wistar Rats
por: Maryam, Tuba, et al.
Publicado: (2023)

Silymarin protects the structure of kidney in the neonatal rats exposed to maternal cadmium toxicity: A stereological study
por: Hamidian, Gholamreza, et al.
Publicado: (2020)

Dehydroflavonolignans from Silymarin Potentiate Transition Metal Toxicity In Vitro but Are Protective for Isolated Erythrocytes Ex Vivo
por: Lomozová, Zuzana, et al.
Publicado: (2021)

Antiviral activity of silymarin against chikungunya virus
por: Lani, Rafidah, et al.
Publicado: (2015)

A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity
por: Singh, Mandeep, et al.
Publicado: (2023)

Silymarin Protects against Acute Liver Injury Induced by Acetaminophen by Downregulating the Expression and Activity of the CYP2E1 Enzyme
por: Yang, Weipei, et al.
Publicado: (2022)

Lifestyle and silymarin: a fight against liver damage in NAFLD associated - prediabetic disease
por: Colletta, Cosimo, et al.
Publicado: (2020)

Free Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin against CCl(4) Induced Rat Liver Damage
por: Abdel-Moneim, Ashraf M., et al.
Publicado: (2015)

Re: “Protective Role of Silymarin and Deferoxamine against Iron Dextran-Induced Renal Iron Deposition in Male Rats,” and “Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model”
por: Mazaheri, Safoora, et al.
Publicado: (2014)

Hematological and liver toxicity of anti-tuberculosis drugs
por: Mirlohi, Maryam-Sadat, et al.
Publicado: (2016)

Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
por: Stilinović, Nebojša, et al.
Publicado: (2012)

Green Synthesis of Silymarin–Chitosan Nanoparticles as a New Nano Formulation with Enhanced Anti-Fibrotic Effects against Liver Fibrosis
por: Abdullah, Abdullah Saad, et al.
Publicado: (2022)

The Effectiveness of Silymarin in the Prevention of Anti-tuberculosis Drug-induced Hepatotoxicity: A Randomized Controlled Clinical Trial
por: Talebi, Ali, et al.
Publicado: (2023)

Protective Role of Silymarin on Hepatic and Renal Toxicity Induced by MTX Based Chemotherapy in Children with Acute Lymphoblastic Leukemia
por: Hagag, Adel A., et al.
Publicado: (2016)

Effect of silymarin in diabetes mellitus patients with liver diseases
por: Jose, Manonmani Alvin, et al.
Publicado: (2011)

Silymarin Accelerates Liver Regeneration after Partial Hepatectomy
por: Wu, Jia-Ping, et al.
Publicado: (2015)

Silymarin Protects Mouse Liver and Kidney from Thioacetamide Induced Toxicity by Scavenging Reactive Oxygen Species and Activating PI3K-Akt Pathway
por: Ghosh, Shatadal, et al.
Publicado: (2016)

Protective Effects of Silymarin Against D-Gal/LPS-Induced Organ Damage and Inflammation in Mice
por: Zhao, Xin, et al.
Publicado: (2021)

Hepatoprotective activities of picroliv, curcumin, and ellagic acid compared to silymarin on carbon-tetrachloride-induced liver toxicity in mice
por: Girish, C., et al.
Publicado: (2012)

Antiviral activity of silymarin and baicalein against dengue virus
por: Low, Zhao Xuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gr7pkccgt8usfaejp5h70qsdol